Resource
About Us
Services & Solutions
News
Contact
Career
Aug 03,2022
Oligonucleotide Drug Development (CMC)
* Explore synthesis strategies and analytical methodologies * Compare the advantages and disadvantages of different formulation strategies * Review the latest CMC strategies and regulatory framework
Watch
Oligonucleotide Drug Discovery
* Examine the synthesis and modification of oligonucleotides* Explore methods for determining pharmacokinetic parameters* Hear about state of the art discovery strategies
Jul 05,2022
Interview: TRENDS IN OLIGONUCLEOTIDE DRUG DEVELOPMENT - A VIRTUAL PANEL DISCUSSION
WuXi STA’s William Fang, Vice President and Head of New Modalities Oligo & Peptide, discussed trends in oligonucleotide drug development in this virtual panel discussion published in the magazine Chemistry Today.
Download
May 12,2022
Brochure: CRDMO platform for Oligonucleotide, Peptide and Complex Conjugate
WuXi STA New Modality CRDMO Business Introduction